Onwuzurike and Paschal: Lions’ Injury Woes of 2025

The Detroit Lions entered 2025 expecting a strong defensive line boost from two 2021 and 2022 second‑round selections, Levi Onwuzurike and Josh Paschal. Both players were sidelined before the season even started, and the uncertainty surrounding their injuries rippled through the franchise’s roster plans. While the team’s top‑10 injury list captured the most high‑profile cases, a bonus #11 story highlighted the parallel struggles of Onwuzurike and Paschal.

Surprise Offseason Surgeries

Each player faced unexpected operations during the offseason, a rare occurrence for athletes entering a new season. Onwuzurike’s ACL problem dated back to the 2024 campaign but was not addressed surgically until after he inked a free‑agent contract. Paschal required back surgery and was immediately placed on the non‑football injury (NFI) list, a designation that sparked immediate curiosity among fans and analysts.

The medical decisions left both athletes missing every game in 2025, depriving the Lions of the defensive depth they had counted on. Paschal’s brief return to practice in November gave a fleeting glimmer of hope, only to be quickly extinguished when he was shut down again. In the end, the surgeries not only cost the team on the field but also reshaped the roster’s financial dynamics.

Mysterious Timelines and Contract Toll

After Onwuzurike’s ACL injury began in 2024, the Lions waited until after his free‑agent signing to operate, a timeline that raised questions about injury management. Paschal’s back surgery and NFI placement were never fully explained, fueling speculation about the true nature of his condition. Despite the unanswered inquiries, both players saw their expiring contracts toll for another year, keeping the Lions’ rights intact for 2026.

The contract toll allowed Detroit to retain the options without absorbing immediate cap hits, a strategic move for a roster rebuild. This mechanism gave the team flexibility to monitor the players’ health without committing long‑term money. The toll also meant that both athletes could still prove themselves, though the window for a 2025 return had already closed.

Roster Impact and Current Status

Onwuzurike remains on the team and still has a chance to make the 53‑man roster for 2026, a scenario that keeps his NFL future alive. In contrast, Paschal was released, ending his tenure with the Lions after a season that never materialized. Both were once prized second‑round assets, but injury misfortunes diverted their trajectories in opposite directions.

The Lions’ injury woes extend beyond the top‑10 list, illustrating how unforeseen medical issues can alter a franchise’s plans. As Detroit looks toward the 2026 campaign, the developments with Onwuzurike and Paschal will likely influence depth charts and free‑agent signing strategies. Fans and analysts will be watching closely to see if either player can return to the form that initially justified their draft picks.

For deeper analysis of the timeline, injuries, and contract tolling, check out Levi Onwuzurike & Josh Paschal: Lions contract tolling and injury analysis.